ANO1 and glioblastoma: In line with these studies, we also found that the pharmacological inhibition of CaMKII with KN-93 or the specific knockdown of CaMKIIβ suppressed the surface expression and channel activity of ANO1 in U251 glioblastoma cells (Figure 2 and Figure 4).